These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 12780750)
1. CTLA4 gene and Graves' disease: association of Graves' disease with the CTLA4 exon 1 and intron 1 polymorphisms, but not with the promoter polymorphism. Vaidya B; Oakes EJ; Imrie H; Dickinson AJ; Perros P; Kendall-Taylor P; Pearce SH Clin Endocrinol (Oxf); 2003 Jun; 58(6):732-5. PubMed ID: 12780750 [TBL] [Abstract][Full Text] [Related]
2. Relation of three polymorphisms of the CTLA-4 gene in patients with Graves' disease. Kouki T; Gardine CA; Yanagawa T; Degroot LJ J Endocrinol Invest; 2002 Mar; 25(3):208-13. PubMed ID: 11936461 [TBL] [Abstract][Full Text] [Related]
3. Polymorphism in the promoter and exon 1 of the cytotoxic T lymphocyte antigen-4 gene associated with autoimmune thyroid disease in Koreans. Park YJ; Chung HK; Park DJ; Kim WB; Kim SW; Koh JJ; Cho BY Thyroid; 2000 Jun; 10(6):453-9. PubMed ID: 10907987 [TBL] [Abstract][Full Text] [Related]
4. No evidence for allelic association of a human CTLA-4 promoter polymorphism with autoimmune thyroid disease in either population-based case-control or family-based studies. Heward JM; Allahabadia A; Carr-Smith J; Daykin J; Cockram CS; Gordon C; Barnett AH; Franklyn JA; Gough SC Clin Endocrinol (Oxf); 1998 Sep; 49(3):331-4. PubMed ID: 9861324 [TBL] [Abstract][Full Text] [Related]
5. Association of cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) gene polymorphism and non-genetic factors with Graves' ophthalmopathy in European and Japanese populations. Bednarczuk T; Hiromatsu Y; Fukutani T; Jazdzewski K; Miskiewicz P; Osikowska M; Nauman J Eur J Endocrinol; 2003 Jan; 148(1):13-8. PubMed ID: 12534352 [TBL] [Abstract][Full Text] [Related]
6. CTLA4 gene polymorphism confers susceptibility to Graves' disease in Japanese. Yanagawa T; Taniyama M; Enomoto S; Gomi K; Maruyama H; Ban Y; Saruta T Thyroid; 1997 Dec; 7(6):843-6. PubMed ID: 9459626 [TBL] [Abstract][Full Text] [Related]
7. CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease. Kouki T; Sawai Y; Gardine CA; Fisfalen ME; Alegre ML; DeGroot LJ J Immunol; 2000 Dec; 165(11):6606-11. PubMed ID: 11086105 [TBL] [Abstract][Full Text] [Related]
8. Association of Graves' disease and Graves' ophthalmopathy with the polymorphisms in promoter and exon 1 of cytotoxic T lymphocyte associated antigen-4 gene. Zhang Q; Yang YM; Lv XY J Zhejiang Univ Sci B; 2006 Nov; 7(11):887-91. PubMed ID: 17048303 [TBL] [Abstract][Full Text] [Related]
10. The common -318C/T polymorphism in the promoter region of CTLA4 gene is associated with reduced risk of ophthalmopathy in Chinese Graves' patients. Han SZ; Zhang SH; Li R; Zhang WY; Li Y Int J Immunogenet; 2006 Aug; 33(4):281-7. PubMed ID: 16893393 [TBL] [Abstract][Full Text] [Related]
11. Association of the T-cell regulatory gene CTLA4 with Graves' disease and autoimmune thyroid disease in the Japanese. Furugaki K; Shirasawa S; Ishikawa N; Ito K; Ito K; Kubota S; Kuma K; Tamai H; Akamizu T; Hiratani H; Tanaka M; Sasazuki T J Hum Genet; 2004; 49(3):166-168. PubMed ID: 14986169 [TBL] [Abstract][Full Text] [Related]
12. CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus. Donner H; Rau H; Walfish PG; Braun J; Siegmund T; Finke R; Herwig J; Usadel KH; Badenhoop K J Clin Endocrinol Metab; 1997 Jan; 82(1):143-6. PubMed ID: 8989248 [TBL] [Abstract][Full Text] [Related]
13. Influence of the TSH receptor gene on susceptibility to Graves' disease and Graves' ophthalmopathy. Yin X; Latif R; Bahn R; Tomer Y; Davies TF Thyroid; 2008 Nov; 18(11):1201-6. PubMed ID: 18925838 [TBL] [Abstract][Full Text] [Related]
14. CTLA-4 promoter variants in patients with Graves' disease and Hashimoto's thyroiditis. Braun J; Donner H; Siegmund T; Walfish PG; Usadel KH; Badenhoop K Tissue Antigens; 1998 May; 51(5):563-6. PubMed ID: 9672157 [TBL] [Abstract][Full Text] [Related]
15. A significant association of the CTLA4 gene variants with the risk of autoimmune Graves' disease in ethnic Kashmiri population. Shehjar F; Dil-Afroze ; Misgar RA; Malik SA; Laway BA Cell Immunol; 2020 Jan; 347():103995. PubMed ID: 31708111 [TBL] [Abstract][Full Text] [Related]
16. CTLA-4 gene polymorphisms in Tunisian patients with Graves' disease. Hadj Kacem H; Bellassoued M; Bougacha-Elleuch N; Abid M; Ayadi H Clin Immunol; 2001 Dec; 101(3):361-5. PubMed ID: 11726229 [TBL] [Abstract][Full Text] [Related]
17. The influence of the exon 1 polymorphism of the cytotoxic T lymphocyte antigen 4 gene on thyroid antibody production in patients with newly diagnosed Graves' disease. Zaletel K; Krhin B; Gaberscek S; Pirnat E; Hojker S Thyroid; 2002 May; 12(5):373-6. PubMed ID: 12097196 [TBL] [Abstract][Full Text] [Related]
18. CT60 single nucleotide polymorphisms of the cytotoxic T-lymphocyte-associated antigen-4 gene region is associated with Graves' disease in an Italian population. Petrone A; Giorgi G; Galgani A; Alemanno I; Corsello SM; Signore A; Di Mario U; Nisticò L; Cascino I; Buzzetti R Thyroid; 2005 Mar; 15(3):232-8. PubMed ID: 15785242 [TBL] [Abstract][Full Text] [Related]
19. MHC class II region, CTLA4 gene, and ophthalmopathy in patients with Graves' disease. Allahabadia A; Heward JM; Nithiyananthan R; Gibson SM; Reuser TT; Dodson PM; Franklyn JA; Gough SC Lancet; 2001 Sep; 358(9286):984-5. PubMed ID: 11583755 [TBL] [Abstract][Full Text] [Related]
20. An association between the CTLA4 exon 1 polymorphism and early rheumatoid arthritis with autoimmune endocrinopathies. Vaidya B; Pearce SH; Charlton S; Marshall N; Rowan AD; Griffiths ID; Kendall-Taylor P; Cawston TE; Young-Min S Rheumatology (Oxford); 2002 Feb; 41(2):180-3. PubMed ID: 11886967 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]